- Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells
Ahmed Al Saqr et al, 2020, AAPS PharmSciTech CrossRef - Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1
Shuxian Chen et al, 2017, Journal of Biosciences and Medicines CrossRef - Glutathione S‐transferase omega 1 inhibition activates JNK‐mediated apoptotic response in breast cancer stem cells
Kanakaraju Manupati et al, 2019, The FEBS Journal CrossRef - Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF‑7 cells
Huan Gao et al, 2018, Experimental and Therapeutic Medicine CrossRef - Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells
Mercedes Garcia-Gil et al, 2021, Pharmaceuticals CrossRef - Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines
Li Chen et al, 2019, AAPS PharmSciTech CrossRef - Synergistic and enhanced anticancer effect of a facile surface modified non-cytotoxic silver nanoparticle conjugated with gemcitabine in metastatic breast cancer cells
Arjunan Karuppaiah et al, 2020, Materials Today Communications CrossRef - Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies
Lama Lozon et al, 2024, Life Sciences CrossRef